282020
Interlocking world of global health governance: Tobacco industry, bilateral investment treaties and health policy
Methods: A standard qualitative research approach was used by triangulating information from tobacco documents' libraries, UN, World Bank, WHO and WTO. Additionally, relevant literature was searched from PubMed, JSTOR and Google Scholar. Hundreds of documents were retrieved and thematically analyzed using Nvivo v9.0 software.
Results: Since mid-1960s, investor-State disputes have been settled mostly through World Bank's ICSID and UN Commission on International Trade Law. The Philip Morris' lawsuits were novel because they were unprecedented use of these fora. In late 1940s, tobacco companies recognized BITs' importance in promoting tobacco and lobbied for them to seek relief from “doubled taxation”. Subsequently, BITs became a means for the industry to globalize tobacco, and challenge States' policy making authority. Particularly, after failing to derail the FCTC, BITs have become the main strategy to stifle progression of global tobacco control.
Conclusion: The study findings suggest the need for either a multilateral treaty or convention on international investment integrating health or at least exclusion of tobacco from BITs and/or BIT-associated tobacco industry privileges such as the right of BITs to sue States.
Learning Areas:
Advocacy for health and health educationPublic health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy
Public health or related research
Learning Objectives:
Describe how the tobacco industry used bilateral investment treaties to aid the globalization of tobacco and undermine policy
Analyze the tobacco industry role in the development of bilateral investment treaties
Provide policymakers and health advocates information on how to influence negotiation of bilateral investment treaties
Keyword(s): Public Health Legislation, Tobacco Industry
Qualified on the content I am responsible for because: I conduct research in global tobacco control with focus on the WHO Framework Convention on Tobacco Control, the interface of international trade/investment and public health, and tobacco control in Africa. The research also involves tobacco industry strategies to market and promote tobacco use worldwide and undermine public health policy and governance.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.